 | Up a level |
Stone, J M; Morrison, P D; Brugger, S; Nottage, J; Bhattacharyya, S; Sumich, A; Wilson, D; Tunstall, N; Feilding, A; Brenneisen, R; McGuire, P; Murray, R M; Ffytche, D H (2012). Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence. Molecular psychiatry, 17(6), pp. 568-9. Basingstoke: Nature Publishing Group 10.1038/mp.2011.141
Schuler, V; Suter, K; Fürer, K; Eberli, D; Horst, M; Betschart, C; Brenneisen, R; Hamburger, M; Mennet, M; Schnelle, M; Simões-Wüst, A P; von Mandach, U (2012). Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips--a pharmacological study towards a new treatment option of overactive bladder. Phytomedicine, 19(10), pp. 947-51. Amsterdam: Elsevier 10.1016/j.phymed.2012.05.003
Morrison, PD; Nottage, J; Stone, JM; Bhattacharyya, S; Tunstall, N; Brenneisen, R; Holt, D; Wilson, D; Sumich, A; McGuire, P; Murray, RM; Kapur, S; Ffytche, DH (2011). Disruption of frontal theta coherence by Δ(9)-tetrahydrocannabinol is associated with positive psychotic symptoms. Neuropsychopharmacology, 36(4), pp. 827-836. Nature Publishing Group 10.1038/npp.2010.222
Wächter, R; Brenneisen, R; Hamburger, M; Mennet, M; Schnelle, M; Worel, A M; Simões-Wüst, A P; von Mandach, U (2011). Leaf press juice from Bryophyllum pinnatum (Lamarck) Oken induces myometrial relaxation. Phytomedicine, 19(1), pp. 74-82. Amsterdam: Elsevier 10.1016/j.phymed.2011.06.032
Hysek, C M; Simmler, L D; Ineichen, M; Grouzmann, E; Hoener, M C; Brenneisen, R; Huwyler, J; Liechti, M E (2011). The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clinical pharmacology & therapeutics, 90(2), pp. 246-55. New York, N.Y.: Nature Publishing Group 10.1038/clpt.2011.78
Berseta, JD; Brenneisen, R; Mathieu, C (2010). Analysis of llicit and illicit drugs in waste, surface and lake water samples using large volume direct injection high performance liquid chromatography – Electrospray tandem mass spectrometry (HPLC–MS/MS). Chemosphere, 81(7), pp. 859-866. Kidlington, UK: Elsevier Science 10.1016/j.chemosphere.2010.08.011
Simões-Wüst, AP; Grãos, M; Duarte, CB; Brenneisen, R; Hamburger, M; Mennet, M; Ramos, MH; Schnelle, M; Wächter, R; Worel, AM; von Mandach, U (2010). Juice of Bryophyllum pinnatum (Lam.) inhibits oxytocin-induced increase of the intracellular calcium concentration in human myometrial cells. Phytomedicine, 17(12), pp. 980-986. Amsterdam: Elsevier 10.1016/j.phymed.2010.03.005
Brenneisen, R; Meyer, P; Chtioui, H; Saugy, M; Kamber, M (2010). Plasma and urine profiles of delta-9-tetrahydrocannabinol (THC) and its metabolites 11-hydroxy-THC and 11-nor-9-carboxy-THC after cannabis smoking by male volunteers to estimate recent consumption of athletes. Analytical and bioanalytical chemistry, 2009(396), pp. 2493-2502510. Heidelberg: Springer-Verlag 10.1007/s00216-009-3431-3
Mareck, U; Haenelt, N; Guyer, H; Guddat, S; Kamber, M; Brenneisen, R; Thevis, M; Schänzer, W (2009). Temporal indication of cannabis use by means of THC glucuronide determination. Drug testing and analysis, 2009(1), pp. 505-510. Chichester: Wiley 10.1002/dta.106
Kosel, M; Noss, R.S.; Hämmig, R; Wielepp, P; Bundeli, P; Heidbreder, R; Kinser, J.A.; Brenneisen, R; Fisch, H.U.; Kayser, S; Schlaepfer, T.E. (2008). Cerebral blood flow effects of acute intravenous heroin administration. European neuropsychopharmacology, 18(4), pp. 278-285. Amsterdam: Elsevier 10.1016/j.euroneuro.2007.11.007
Netzer, P; Sendensky, A; Wissmeyer, M P; Baumeler, S; Batista, C; Scheurer, U; Krause, T; Reber, P; Brenneisen, R (2008). The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study. Alimentary pharmacology & therapeutics, 28(11-12), pp. 1334-41. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2008.03855.x
Hagenbach, U; Luz, S; Ghafoor, N; Berger, J M; Grotenhermen, F; Brenneisen, R; Mäder, M (2007). The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury. Spinal cord, 45(8), pp. 551-62. Basingstoke: Nature Publishing Group 10.1038/sj.sc.3101982
Netzer, P; Wissmeyer, MP; Sendensky, A; Batista, C; Baumeler, S; Brenneisen, R; Krause, T; Reber, P; Gschossmann, JM; Scheurer, U (2006). The effect of naloxone-3-glucuronide (NX3G) on gastro-coecal transit time in healthy volunteers under morphine medication. Gastroenterology(130), A291-292. Philadelphia, Pa.: Elsevier
